Initial Experience With Conivaptan Use in Critically Ill Infants With Cardiac Disease

OBJECTIVE: Arginine vasopressin (AVP) is the primary regulator of free water retention through its interactions with the AVP type 2 receptor (V(2)). As opposed to the natriuresis and diuresis that occur with loop and thiazide diuretics, conivaptan is an AVP V(1A)/V(2) receptor antagonist, which enha...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Jones, Ryan C., Rajasekaran, Surender, Rayburn, Mark, Tobias, Joseph D., Kelsey, Robert M., Wetzel, Glenn T., Cabrera, Antonio G.
Formato: Artigo
Idioma:Inglês
Publicado em: Pediatric Pharmacy Advocacy Group 2012
Assuntos:
Clinical Investigations
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3428191/
https://ncbi.nlm.nih.gov/pubmed/23118660
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5863/1551-6776-17.1.78
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados